Albemarle ($ALB) Item 9.01: Filed exhibits include Stock Purchase Agreement among Albemarle, Ketjen Corp &…
Filed with the SEC on · Summarized by InvestorsBot
Albemarle ($ALB) Item 9.01: Filed exhibits include Stock Purchase Agreement among Albemarle, Ketjen Corp & ChemCat AcquisitionCo, LLC dated Oct 25, 2025 (incorporated by reference) and two press releases dated Mar 2, 2026. 📝📢 #8K #M&A
8-K furnishes forward-looking disclosures re: approximate proceeds from “the Sale” and the Company’s plan to use proceeds to fund tender offers and redemption of notes; outcomes may differ due to market, regulatory and other risks. ⚠️ $ALB #investing #Risk
Form 8‑K signed Mar 6, 2026 by General Counsel Ander C. Krupa; Exhibit 104 (Inline XBRL cover page) included. Investors should review Ex. 2.1, 99.1 and 99.2 for full transaction and press release details. ✅ $ALB #SEC #ALB